FDA Uncovers Violations At Sanofi Vaccine Plant
The vaccines division of Sanofi-Aventis failed to follow manufacturing procedures at a French plant where the pharmaceutical giant makes its Imovax rabies vaccine, according to the U.S. Food and Drug Administration....To view the full article, register now.
Already a subscriber? Click here to view full article